Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fa0344d0725b4c7788695fafcc3f18e8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|